Director, Global Medical Oncology, Emerging Assets

Role Summary

Director, Global Medical Oncology, Emerging Assets. Lead the global medical strategy for the Iza-bren asset, collaborating with cross-functional teams to shape the medical vision and drive execution across the asset lifecycle in a rapidly evolving oncology landscape.

Responsibilities

• Drive the development and execution of the global medical strategy for Iza-bren, ensuring alignment with clinical development, commercial, and access teams.
• Serve as an advisor and collaborator to the MPL to support the Global Product Team (GPT) and cross-functional launch teams.
• Translate clinical development insights into medical plans that support launch readiness and lifecycle management.
• Engage with key external stakeholders including thought leaders, investigators, and advocacy groups to gather insights and foster scientific exchange.
• Represent BMS at global oncology congresses and forums, elevating the visibility of Iza-bren and its clinical value.
• Partner with R&D to influence trial design, endpoints, and data generation strategies for Iza-bren.
• Collaborate with Commercial, Market Access, and HEOR to integrate medical perspectives into brand strategy and patient journey mapping.
• Work closely with Medical Communications teams to ensure scientific alignment and impactful dissemination of data.
• Lead the medical planning process for Iza-bren, including budgeting, resource forecasting, and performance tracking.
• Provide medical review and strategic input for content development, ensuring consistency with asset strategy.
• Facilitate matrix meetings and ensure effective follow-up on decisions, risks, and action items.
• Identify opportunities for innovation in medical execution, including digital engagement and real-world evidence generation.
• Contribute to broader Oncology initiatives such as Project Converge and strategic planning across Thoracic and H&N tumors.
• Support business development evaluations and alliance partnerships relevant to Iza-bren.

Qualifications

• Advanced scientific degree (MD, PhD, PharmD) with oncology specialization preferred.
• Minimum 5-7 years of experience in medical affairs or clinical development within the biopharmaceutical industry.
• Proven leadership in global medical strategy and cross-functional team management.
• Strong understanding of oncology therapeutic landscape, particularly thoracic cancers.
• Excellent communication, stakeholder engagement, and strategic planning skills.